Press Releases - May 31, 2016
Of Coverage Guidelines for Opioid Abuse Deterrent Drugs
To help address the opioid epidemic sweeping the nation and now confronting Connecticut, Insurance Commissioner Katharine L. Wade is reminding health insurers that FDA-approved opioid abuse deterrent drugs prescribed for pain management purposes must be covered if medically necessary.
“The epidemic tears apart families and ruins lives and must be addressed on several fronts,” Commissioner Wade said. “That is the intent behind Public Act 16-43. The law Governor Malloy recently signed the law will go a long way in helping Connecticut communities combat this scourge.”
The Department’s bulletin HC-112 issued May 31, 2016 cites state law and federal guidance governing insurance companies’ drug lists, also known as formularies. Under the Affordable Care Act, drug lists are required to cover “at least the greater of one drug in every category and class or the same number of drugs in each category and class as the benchmark plan.”
“We are making certain that consumers have access to these drugs and that their providers have the tools and flexibility to prescribe the drug that best meets their needs,” Commissioner Wade said.
- Ask a question or file a complaint online
- Call the Consumer Helpline at 800-203-3447 or 860-297-3900.
- Sign up for e-alerts to get the latest news, warnings and rate changes that may affect your premium
- Download consumer FAQs on health, homeowner and auto coverage
- Use the Department’s Speakers Bureau for public events.
- Visit our Web site and follow the Department on Facebook, Twitter or YouTube